Dailyrep.net
Technology

WHO suspends trials of drug that Trump is taking over safety fears

The World Health Organisation is removing hydroxychloroquine from its global study of potential COVID-19 treatments while it carries out a review of its safety.

Last week, Donald Trump said he was taking the anti-malarial drug, which he has promoted as providing possible protection from coronavirus, despite warnings from health officials that it could cause heart problems.

The decision by the WHO to temporarily suspend hydroxychloroquine from its study follows a paper published in The Lancet last week which suggested it might actually increase the risk for COVID-19 patients.

:: Listen to Divided States on Apple podcasts, Google Podcasts, Spotify, and Spreaker

In a study of 96,000 coronavirus patients, almost 15,000 were given hydroxychloroquine – or a related form chloroquine – either alone or with an antibiotic.

It found that death rates for those treated with hydroxychloroquine were 18%, compared with 16.4% for chloroquine and 9% for the control group.

Those treated with hydroxychloroquine or chloroquine in combination with antibiotics had an even higher death rate.

More from World

WHO director-general Tedros Adhanom Ghebreyesus said that, in light of the research, there would be “a temporary pause” on the hydroxychloroquine arm of its global clinical trial.

Other treatments in the study, including the experimental anti-viral drug remdesivir, which was originally developed to combat ebola, and an HIV combination therapy, are still being pursued.

Donald Trump has admitted to taking the controversial drug for over a week, despite concerns over dangerous side effects
19 May: ‘Yeah I’m taking it, and I’m still here’

In a television interview on Sunday, Mr Trump confirmed he had just finished a two-week course of hydroxychloroquine and that he was “still here”.

When asked about his use of the drug by Sinclair Broadcast Group’s Sharyl Attkisson, the president said: “Well, I’ve heard tremendous reports about it. Frankly, I’ve heard tremendous reports. Many people think it saved their lives. Doctors come out with reports.

“You had a study in France, you had a study in Italy that were incredible studies. Look, if somebody else were promoting it other than me, call it a promotion because I want people to get better.

“I don’t get anything. I don’t gain anything other than if it’s something that helps, that’s a good thing. That’s what I want.”

Related posts

BA fine for losing customers’ credit card details dropped by £163m

admin

Amazon surge as sales beat targets and Prime membership soars

admin

Mass COVID-19 screening possible in ‘weeks’

admin